In September 2014, we were delighted to announce Hartford HealthCare Cancer Institute (HHCCI) — which comprises the five cancer programs of Hartford HealthCare’s multihospital system in Connecticut — as a fully certified member in the Memorial Sloan Kettering Cancer Alliance.
Certification comes after a year of intensive review and analysis of six disease specialties (breast, colorectal, kidney, lung, prostate, and uterine) and 11 disciplines across the institute. During that time, hundreds of experts and specialists from both organizations worked together to assess HHCCI’s resources and capabilities, and to develop plans to mitigate any gaps, with the ultimate goal of establishing a single, elevated standard of care across all five cancer programs.
HHCCI doctors are in the process of being integrated into our multidisciplinary disease management teams and will eventually participate in MSK clinical research. Hartford HealthCare Cancer Institute nurses, pharmacists, imaging experts, and other care providers have also undergone training.
In addition, we are jointly recruiting a Physician-in-Chief of the Hartford Healthcare Cancer Institute who will be on staff at both HHCCI and Memorial Sloan Kettering. Among the many distinctive aspects of the collaboration still under way is the establishment of the first MSK Cancer Alliance clinical trials site.
As we continue to make progress together, HHCCI will be empowered to keep learning, adapting to, and adopting MSK’s standards of care within the context of its own institution and in the context of the communities it serves. Future projects include conducting joint quality and outcomes research in order to measure the success of our relationship, as well as exploring collaborations beyond the six disease specialties.